Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML)

NCT00746941 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

37

Enrollment

INDUSTRY

Sponsor class

Stopped Primary endpoint not achieved

Conditions

Progressive Multifocal Leukoencephalopathy

Interventions

DRUG: mefloquine

Sponsor

Biogen

Collaborators

[object Object]